Nations Financial Group Inc. IA ADV Sells 19,165 Shares of CVS Health Co. (NYSE:CVS)

Nations Financial Group Inc. IA ADV reduced its holdings in shares of CVS Health Co. (NYSE:CVS) by 71.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,828 shares of the pharmacy operator’s stock after selling 19,165 shares during the quarter. Nations Financial Group Inc. IA ADV’s holdings in CVS Health were worth $462,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of CVS Health by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 117,696,285 shares of the pharmacy operator’s stock valued at $9,293,299,000 after purchasing an additional 533,659 shares in the last quarter. Capital World Investors boosted its position in CVS Health by 8.0% in the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after buying an additional 3,232,172 shares in the last quarter. Capital International Investors grew its stake in shares of CVS Health by 12.5% during the first quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock worth $3,024,334,000 after buying an additional 4,226,225 shares during the last quarter. Norges Bank acquired a new position in shares of CVS Health during the fourth quarter worth $1,092,040,000. Finally, Capital Research Global Investors lifted its stake in shares of CVS Health by 1.4% in the 1st quarter. Capital Research Global Investors now owns 13,143,822 shares of the pharmacy operator’s stock valued at $1,048,351,000 after acquiring an additional 184,297 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CVS. Evercore ISI lowered their target price on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Baird R W upgraded shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Barclays reduced their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, August 8th. JPMorgan Chase & Co. dropped their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Finally, Bank of America cut their price target on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Eleven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $73.24.

CVS Health Trading Up 0.5 %

Shares of CVS stock traded up $0.27 during trading hours on Friday, hitting $57.24. 8,156,873 shares of the company were exchanged, compared to its average volume of 11,181,803. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a 50 day simple moving average of $58.59 and a two-hundred day simple moving average of $64.66. The firm has a market cap of $71.86 billion, a P/E ratio of 10.06, a P/E/G ratio of 0.57 and a beta of 0.52.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. During the same quarter in the prior year, the business earned $2.21 earnings per share. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. Equities analysts anticipate that CVS Health Co. will post 7 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.65%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.